Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Xtacy Therapeutics (XTCYF)

OTHER OTC:XTCYF

XTCYF

Xtacy Therapeutics

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Xtacy Therapeutics (XTCYF) Income Statement

4 Followers

Xtacy Therapeutics Income Statement

Last quarter (Q1 2024), Xtacy Therapeutics's total revenue was C$―, a decrease of ― from the same quarter last year. In Q1, Xtacy Therapeutics's net income was C$-265.84K. See Xtacy Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Total Revenue	C$ 21.82K	C$ 21.82K	-	-	C$ 101.87K	C$ 112.28K
Cost of Revenue	-	-	-	C$ 1.51K	C$ 0.00	-
Gross Profit	C$ 21.82K	C$ 21.82K	-	C$ -1.51K	C$ 101.87K	-
Operating Expense	C$ 1.05M	C$ 940.80K	C$ 1.38M	C$ 3.88M	C$ 696.31K	C$ 2.82M
Operating Income	C$ -1.03M	C$ -918.98K	C$ -1.38M	C$ -3.88M	C$ -594.44K	C$ -2.71M
Net Non Operating Interest Income Expense	C$ -5.28K	-	C$ -4.59K	C$ 1.57K	C$ -1.95K	C$ -2.62K
Other Income Expense	C$ -437.10K	C$ -401.33K	C$ -11.43K	C$ 298.05K	C$ -778.60K	C$ 338.14K
Pretax Income	C$ -597.41K	C$ -519.94K	C$ -1.37M	C$ -3.58M	C$ -1.37M	C$ -2.37M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -597.41K	C$ -519.94K	C$ -1.37M	C$ -3.58M	C$ -1.37M	C$ -2.37M
Basic EPS	C$ -0.02	C$ -0.01	C$ -0.05	C$ -0.23	C$ -0.10	C$ -0.20
Diluted EPS	C$ -0.02	C$ -0.01	C$ -0.05	C$ -0.23	C$ -0.10	C$ -0.20
Basic Average Shares	C$ 189.56M	C$ 43.55M	C$ 27.15M	C$ 15.87M	C$ 13.83M	C$ 12.12M
Diluted Average Shares	C$ 189.56M	C$ 43.55M	C$ 27.15M	C$ 15.87M	C$ 13.83M	C$ 12.12M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	C$ 7.19K
Total Expenses	C$ 1.05M	C$ 940.80K	C$ 1.38M	-	C$ 696.31K	C$ 2.82M
Interest Expense	-	-	-	-	-	C$ 2.62K
Net Income From Continuing And Discontinued Operation	C$ -597.41K	C$ -519.94K	C$ -1.37M	C$ -3.58M	C$ -1.37M	C$ -2.37M
Normalized Income	C$ -506.88K	C$ -382.15K	C$ -1.01M	C$ -2.93M	C$ -526.68K	C$ -2.44M
EBIT	C$ -594.07K	C$ -517.65K	C$ -1.36M	C$ -3.58M	C$ -594.44K	C$ -2.71M
EBITDA	C$ -594.07K	C$ -517.65K	C$ -1.36M	C$ -3.58M	C$ -594.44K	C$ -2.71M

Currency in CAD

Xtacy Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing